Analysis
R&D Cuts Follow Moderna C-19 Business Slump
R&D Cuts Follow Moderna C-19 Business Slump Shares Tumble. Moderna executives just need another pandemic to clear all the uncertainty from the air… Moderna’s post-pandemic future remains highly uncertain. The company revealed new plans to slash $1.1 billion […]